Advanced Biomed Inc.
ADVB
$0.94
$0.00951.02%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -16.55% | -27.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.10% | -28.28% | |||
| Operating Income | -1.10% | 28.28% | |||
| Income Before Tax | -241.83% | 71.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -241.83% | 71.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -241.83% | 71.53% | |||
| EBIT | -1.10% | 28.28% | |||
| EBITDA | -2.13% | 37.85% | |||
| EPS Basic | -241.35% | 71.46% | |||
| Normalized Basic EPS | -242.17% | 71.58% | |||
| EPS Diluted | -241.35% | 71.46% | |||
| Normalized Diluted EPS | -242.17% | 71.58% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||